Bromodomain and extra-terminal (BET) inhibitor INCB057643 (LIMBER-103) in patients (pts) with relapsed or refractory myelofibrosis (R/R MF) and other advanced myeloid neoplasms: A phase 1 study.

被引：0
|
作者：
Watts, Justin M.
Hunter, Anthony
Iurlo, Alessandra
Xicoy, Blanca
Palandri, Francesca
Reeves, Brandi
Vannucchi, Alessandro M.
Bose, Prithviraj
Diaz, Rosa Ayala
Halpern, Anna B.
Chen, Xuejun
Seguy, Francis
Zhou, Feng
Zheng, Fred
Vachhani, Pankit
机构：
[1] Univ Miami, Sylvester Canc Ctr, Miami, FL USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
[3] Maggiore Policlin, Fdn IRCCS Ca Granda Osped, Milan, Italy
[4] Univ Autonoma Barcelona, Hosp Germans Trias i Pujol, Inst Catala Oncol, Josep Carreras Leukemia Res Inst, Barcelona, Spain
[5] Univ Bologna, IRCCS, Azienda Osped, Ist Ematol Seragnoli, Bologna, Italy
[6] Univ North Carolina Chapel Hill, Div Hematol Oncol, Chapel Hill, NC USA
[7] Univ Florence, AOU Careggi, Florence, Italy
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[9] Hosp Univ 12 Octubre, Madrid, Spain
[10] Univ Washington, Med Ctr, Div Hematol, Fred Hutchinson Canc Ctr, Seattle, WA USA
[11] Incyte Corp, Wilmington, DE USA
[12] Incyte Biosci Int Sarl, Morges, Switzerland
[13] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7069
引用
收藏
页数：1
相关论文
共 20 条
  • [1] Bromodomain and Extra-Terminal (BET) Inhibitor INCB057643 (LIMBER-103) in Patients With Relapsed or Refractory Myelofibrosis (R/R MF) and Other Advanced Myeloid Neoplasms: A Phase I Study
    Watts, Justin
    Hunter, Anthony
    Iurlo, Alessandra
    Xicoy, Blanca
    Palandri, Francesca
    Reeves, Brandi
    Vannucchi, Alessandro
    Bose, Prithviraj
    Diaz, Rosa
    Halpern, Anna
    Chen, Xuejun
    Burke, Lea
    Zhou, Feng
    Zheng, Fred
    Vachhani, Pankit
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S403 - S404
  • [2] Bromodomain and Extra-Terminal Inhibitor INCB057643 (LIMBER-103) in Patients with Relapsed or Refractory Myelofibrosis and Other Advanced Myeloid Neoplasms: A Phase 1 Study
    Watts, Justin M.
    Vannucchi, Alessandro M.
    Hunter, Anthony M.
    McMahon, Brandon
    Tantravahi, Srinivas K.
    Iurlo, Alessandra
    Xicoy, Blanca
    Palandri, Francesca
    Searle, Emma
    Reeves, Brandi N.
    Bose, Prithviraj
    Ayala, Rosa
    Halpern, Anna B.
    Chen, Xuejun
    Burke, Lea M.
    Zhou, Feng
    Zheng, Fred
    Vachhani, Pankit
    BLOOD, 2023, 142
  • [3] Bromodomain and extra-terminal (BET) inhibitor INCB057643 in patients with relapsed or refractory myelofibrosis (MF) and other advanced myeloid neoplasms: A phase 1 study
    Watts, Justin M.
    Vannucchi, Alessandro M.
    Hunter, Anthony
    McMahon, Brandon
    Tantravahi, Srinivas Kiran
    Iurlo, Alessandra
    Xicoy, Blanca
    Palandri, Francesca
    Searle, Emma
    Reeves, Brandi
    Bose, Prithviraj
    Diaz, Rosa Ayala
    Halpern, Anna B.
    Chen, Xuejun
    Burke, Lea Micaletti
    Zhou, Feng
    Zheng, Fred
    Vachhani, Pankit
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Bromodomain and Extra-terminal (BET) Inhibitor INCB057643 in Patients With Relapsed or Refractory Myelofibrosis and Other Advanced Myeloid Neoplasms: A Phase 1 Study
    Vachhani, Pankit
    Vannucchi, Alessandro M.
    Hunter, Anthony M.
    McMahon, Brandon
    Tantravahi, Srinivas K.
    Iurlo, Alessandra
    Xicoy, Blanca
    Palandri, Francesca
    Searle, Emma
    Reeves, Brandi
    Bose, Prithviraj
    Diaz, Rosa Ayala
    Halpern, Anna B.
    Chen, Xuejun
    Burke, Lea
    Zhou, Feng
    Zheng, Fred
    Watts, Justin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S415 - S415
  • [5] A Phase 1 Study of INCB057643 Monotherapy in Patients with Relapsed or Refractory Myelofibrosis (INCB 57643-103)
    Lihou, Christine
    Zhou, Gongfu
    Zheng, Fred
    BLOOD, 2020, 136
  • [6] A phase 1 study of INCB057643 monotherapy in patients with relapsed or refractory myelofibrosis (INCB 57643-103)
    Vachhani, Pankit
    Lihou, Christine
    Zhou, Gongfu
    Zheng, Fred
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 112 - 112
  • [7] A Phase 1 Study of INCB057643 Monotherapy in Patients with Relapsed or Refractory Myelofibrosis (INCB 57643-103).
    Vachhani, Pankit
    Lihou, Christine
    Zhou, Gongfu
    Zheng, Fred
    CANCER RESEARCH, 2021, 81 (13)
  • [8] Preliminary Results from an Ongoing Phase 1/2 Study of INCB057643, a Bromodomain and Extraterminal (BET) Protein Inhibitor, in Patients (pts) with Advanced Malignancies
    Forero-Torres, Andres
    Rosen, Seth
    Smith, David C.
    Lesser, Glenn
    Peguero, Julio
    Gupta, Shilpa
    Watts, Justin M.
    Noel, Marcus
    Kurzrock, Razelle
    Park, Haeseong
    LoRusso, Patricia
    Coombs, Catherine C.
    Zheng, Fred
    Switzky, Julie
    Yeleswaram, Swamy
    Falchook, Gerald
    BLOOD, 2017, 130
  • [9] CC-90010, a reversible, oral bromodomain and extra-terminal (BET) inhibitor in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory (R/R) non-Hodgkin lymphoma: Updated results of a phase I study
    Moreno, V.
    Brana, I.
    Sepulveda Sanchez, J. M.
    Vieito, M.
    Hernandez-Guerrero, T.
    Doger, B.
    Saavedra, O.
    Carlo-Stella, C.
    Michot, J-M.
    Italiano, A.
    Musuraca, G.
    Sarmiento, R.
    Amoroso, B.
    Mora, S.
    Sanchez-Perez, T.
    Aronchik, I.
    Filvaroff, E.
    Hanna, B.
    Nikolova, Z.
    Pinto, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S463 - S464
  • [10] Phase I dose-finding study of a novel bromodomain and extra-terminal domain (BET) inhibitor (BI 894999) in patients (pts) with advanced malignancies
    Bechter, O.
    Aftimos, P.
    Awada, A.
    Rottey, S.
    Machiels, J. P.
    Dumez, H.
    Jungels, C.
    Costermans, J.
    Huyvaert, N.
    Zografos, E.
    Meeus, M. A.
    Musa, H.
    Burkard, U.
    Zhao, Y.
    Schoffski, P.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E16 - E16
12